Expression of Alzheimer’s Disease-associated Presenilin-1 Is Controlled by Proteolytic Degradation and Complex Formation
Open Access
- 1 November 1998
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 273 (48), 32322-32331
- https://doi.org/10.1074/jbc.273.48.32322
Abstract
No abstract availableKeywords
This publication has 66 references indexed in Scilit:
- Additive Effects of PS1 and APP Mutations on Secretion of the 42-Residue Amyloid β-ProteinNeurobiology of Disease, 1998
- The Presenilin 1 Protein Is a Component of a High Molecular Weight Intracellular Complex That Contains β-CateninJournal of Biological Chemistry, 1998
- A Presenilin-1 Truncating Mutation Is Present in Two Cases with Autopsy-Confirmed Early-Onset Alzheimer DiseaseAmerican Journal of Human Genetics, 1998
- Cellular Expression and Proteolytic Processing of Presenilin Proteins Is Developmentally Regulated During Neuronal DifferentiationJournal of Neurochemistry, 1997
- Specific Increase in Amyloid β-Protein 42 Secretion Ratio by Calpain InhibitionBiochemistry, 1997
- Apoptosis by Death FactorCell, 1997
- Familial Alzheimer's Disease–Linked Presenilin 1 Variants Elevate Aβ1–42/1–40 Ratio In Vitro and In VivoNeuron, 1996
- Characterization of human presenilin 1 using N‐terminal specific monoclonal antibodies: Evidence that Alzheimer mutations affect proteolytic processingFEBS Letters, 1996
- Amyloid β-peptide is produced by cultured cells during normal metabolismNature, 1992
- Processing of the Amyloid Protein Precursor to Potentially Amyloidogenic DerivativesScience, 1992